Clinical Trial: Randomized Controlled Study on Efficacy and Safety of Subcutaneous Methotrexate Injection in the Treatment of Active Takayasu Arteritis (China)

China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Randomized Controlled Study on Efficacy and Safety of Subcutaneous Methotrexate Injection in the Treatment of Active Takayasu Arteritis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132558

Registration Time: 2026/09/15

Type: Interventional study

Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335856

Published by HT Digital Content Services with permission from Health Daily Digest....